array(3) { ["company_details"]=> array(13) { ["name"]=> string(28) "Bristol-Myers Squibb Company" ["slug"]=> string(37) "81631-us-bristol-myers-squibb-company" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/7b41874f-2658-484b-890c-9b9bd5a41f13" ["description"]=> string(1400) "At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html" ["address_street"]=> string(19) "430 E 29TH St FL 14" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1887-02-28" ["website_domain"]=> string(7) "bms.com" ["website_url"]=> string(19) "https://www.bms.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(1200) ["article_count"]=> int(2495) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(76) "Two COVID Shots Raise Risk of Anaphylaxis, Heart Issues in Older Adolescents" ["snippet_en"]=> string(288) "A Norwegian study found a low but significant risk of serious side effects among adolescents a short time following a second COVID-19 vaccination. The tenfold higher risk for anaphylaxis was the most concerning outcome, but the researchers also found swollen lymph nodes and heart issues." ["url"]=> string(104) "https://childrenshealthdefense.org/defender/two-covid-vaccines-risk-anaphylaxis-heart-older-adolescents/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3366a6eb-e92a-418b-a409-68a8a5b05a6b" ["source"]=> string(26) "childrenshealthdefense.org" ["publication_date"]=> string(10) "2024-01-11" ["categories"]=> array(3) { [0]=> string(17) "Academic Research" [1]=> string(5) "R & D" [2]=> string(8) "Epidemic" } } [1]=> array(7) { ["title_en"]=> string(66) "Moderna rakes in surprise profits ahead of 400% vaccine price hike" ["snippet_en"]=> string(296) "The plump profits haven't changed the company's plans for its COVID-19 vaccines. In an earnings call Thursday, Moderna Chief Commercial Officer Arpa Garay confirmed that the company is still proceeding with the 400 percent increase as the vaccines move from federal distribution to the commercial" ["url"]=> string(110) "https://arstechnica.com/science/2023/05/moderna-rakes-in-surprise-profits-ahead-of-400-vaccine-price-hike/amp/" ["image_url"]=> NULL ["source"]=> string(15) "arstechnica.com" ["publication_date"]=> string(10) "2023-05-05" ["categories"]=> array(1) { [0]=> string(8) "Epidemic" } } [2]=> array(7) { ["title_en"]=> string(76) "JPM23, Day 1: Pfizer CEO shares pandemic predictions; BMS touts new launches" ["snippet_en"]=> string(277) "For the first time in three years, biopharma executives, investors, reporters and others are converging on the Westin St. Francis in San Francisco for the J.P. Morgan Healthcare Conference. | As the J.P. Morgan Healthcare Conference gets underway, two drugmakers inked buyouts." ["url"]=> string(117) "https://www.fiercepharma.com/pharma/jpm23-day-1-chiesi-ipsen-ink-ma-deals-bluebird-touts-gene-therapy-launch-progress" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c894d239-ec84-4fe5-b0ff-5765f85da6d8" ["source"]=> string(16) "fiercepharma.com" ["publication_date"]=> string(10) "2023-01-10" ["categories"]=> array(3) { [0]=> string(8) "Epidemic" [1]=> string(14) "Product Launch" [2]=> string(5) "Event" } } [3]=> array(7) { ["title_en"]=> string(87) "N.J. health officials are recruiting children under 5 for COVID bivalent vaccine trials" ["snippet_en"]=> string(122) "Children under 5 years old are the last remaining group of people who are not yet eligible for COVID-19 bivalent vaccines." ["url"]=> string(81) "https://whyy.org/articles/new-jersey-covid-bivalent-vaccines-children-under-five/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/1a9e2250-f397-4b74-86cc-a4c02718a51e" ["source"]=> string(8) "whyy.org" ["publication_date"]=> string(10) "2022-11-14" ["categories"]=> array(3) { [0]=> string(8) "Epidemic" [1]=> string(20) "Business Development" [2]=> string(10) "Misconduct" } } [4]=> array(7) { ["title_en"]=> string(52) "7 Drug Stocks to Buy Now While They're Still on Sale" ["snippet_en"]=> string(133) "Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead." ["url"]=> string(86) "https://investorplace.com/2021/11/7-drug-stocks-to-buy-now-while-theyre-still-on-sale/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a343d73e-5a37-401a-a683-1431456d0abf" ["source"]=> string(17) "investorplace.com" ["publication_date"]=> string(10) "2021-11-30" ["categories"]=> array(8) { [0]=> string(10) "Cybercrime" [1]=> string(24) "Quarterly/Annual Figures" [2]=> string(12) "Stock Market" [3]=> string(8) "Epidemic" [4]=> string(13) "Collaboration" [5]=> string(11) "Air Quality" [6]=> string(5) "Event" [7]=> string(18) "General Investment" } } [5]=> array(7) { ["title_en"]=> string(100) "New All-Strain Covid Killer to be Tested by a Division of the National Academy of Science of Ukraine" ["snippet_en"]=> string(100) "New All-Strain Covid Killer to be Tested by a Division of the National Academy of Science of Ukraine" ["url"]=> string(159) "https://markets.businessinsider.com/news/stocks/new-all-strain-covid-killer-to-be-tested-by-a-division-of-the-national-academy-of-science-of-ukraine-1031008198" ["image_url"]=> string(78) "https://images.businessradar.com/articles/cdd6330a-fe63-413b-bc1d-7a2398a67ecd" ["source"]=> string(19) "businessinsider.com" ["publication_date"]=> string(10) "2021-11-29" ["categories"]=> array(2) { [0]=> string(8) "Epidemic" [1]=> string(3) "War" } } [6]=> array(7) { ["title_en"]=> string(89) "'Public health as a popularity contest': Why most Indiana mandates aren't coming back yet" ["snippet_en"]=> string(134) "Even though lawmakers haven’t been at the Statehouse for months, their actions are still impacting the COVID-19 response in Indiana." ["url"]=> string(137) "https://www.indystar.com/story/news/politics/2021/09/10/covid-vaccine-indiana-government-mask-mandates-cases-hospitalizations/5757024001/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c9763f61-c757-4f9c-86cc-a01f9a100484" ["source"]=> string(12) "indystar.com" ["publication_date"]=> string(10) "2021-09-10" ["categories"]=> array(4) { [0]=> string(8) "Epidemic" [1]=> string(10) "Litigation" [2]=> string(16) "Case Settlements" [3]=> string(5) "Legal" } } [7]=> array(7) { ["title_en"]=> string(55) "Pandemic Hit Sales Of Cancer, Arthritis, Diabetes Drugs" ["snippet_en"]=> string(196) "Meanwhile, an experimental Alzheimer’s drug seems to help patients with Fragile X syndrome; monoclonal antibodies are in the news again; and a study links dental opioid prescriptions with ove…" ["url"]=> string(87) "https://khn.org/morning-breakout/pandemic-hit-sales-of-cancer-arthritis-diabetes-drugs/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/0f6b1044-8b56-44e7-8804-e2818e69a694" ["source"]=> string(7) "khn.org" ["publication_date"]=> string(10) "2021-04-30" ["categories"]=> array(2) { [0]=> string(8) "Epidemic" [1]=> string(19) "New Revenue Streams" } } [8]=> array(7) { ["title_en"]=> string(61) "Here’s Why Bristol Myers Squibb Stock Is Undervalued At $63" ["snippet_en"]=> string(212) "Bristol Myers Squibb (NYSE: BMY) looks very attractive at current levels of $63, as it is up only 40% from the levels it was at on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19." ["url"]=> string(116) "https://www.forbes.com/sites/greatspeculations/2021/03/29/heres-why-bristol-myers-squibb-stock-is-undervalued-at-63/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/42061d1f-18fa-4c3d-aa94-acd5131d6791" ["source"]=> string(10) "forbes.com" ["publication_date"]=> string(10) "2021-03-29" ["categories"]=> array(1) { [0]=> string(8) "Epidemic" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(254) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(163) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(151) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(94) } [4]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(89) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(76) } [6]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(74) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(64) } [8]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(63) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(60) } [10]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(60) } [11]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(56) } [12]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(54) } [13]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(47) } [14]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(47) } [15]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(45) } [16]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(45) } [17]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(42) } [18]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(39) } [19]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(35) } [20]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(35) } [21]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(33) } [22]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(32) } [23]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(28) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(27) } [25]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [26]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(24) } [27]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(22) } [28]=> array(2) { ["name"]=> string(9) "Valuation" ["count"]=> int(21) } [29]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(21) } } } 81631-us-bristol-myers-squibb-company